BA
CCXI

BlackRock Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

BlackRock Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.02M Sell
138,294
-64,197
-32% -$462K ﹤0.01% 1848
2016
Q3 		$1.22M Sell
202,491
-3,182
-2% -$15K ﹤0.01% 1714
2016
Q2 		$923K Buy
205,673
+88,325
+75% +$331K ﹤0.01% 1793
2016
Q1 		$292K Buy
117,348
+27,655
+31% +$101K ﹤0.01% 2361
2015
Q4 		$727K Buy
89,693
+76,287
+569% +$540K ﹤0.01% 1898
2015
Q3 		$81K Sell
13,406
-1,337
-9% -$9.67K ﹤0.01% 3176
2015
Q2 		$121K Buy
14,743
+1,495
+11% +$11.9K ﹤0.01% 3089
2015
Q1 		$100K Buy
13,248
+2,668
+25% +$20.8K ﹤0.01% 3039
2014
Q4 		$72K Sell
10,580
-1,085
-9% -$5.74K ﹤0.01% 3187
2014
Q3 		$52K Hold
11,665
– – ﹤0.01% 3260
2014
Q2 		$68K Sell
11,665
-1,911
-14% -$10.7K ﹤0.01% 3201
2014
Q1 		$90K Buy
13,576
+1,564
+13% +$10.9K ﹤0.01% 3076
2013
Q4 		$70K Sell
12,012
-32,587
-73% -$168K ﹤0.01% 3170
2013
Q3 		$248K Sell
44,599
-23,818
-35% -$258K ﹤0.01% 2406
2013
Q2 		$967K Buy
+68,417
New +$887K ﹤0.01% 1399

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors's CCXI Position: Q4 2016 in Review

BlackRock Advisors reduced its ChemoCentryx, Inc. (CCXI) stake by 32% in Q4 2016, selling an estimated $462K and leaving 138,294 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

BlackRock Advisors first reported a position in CCXI in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.22M in Q3 2016. 89 funds tracked by Wall St. Rank hold CCXI as of Q4 2016.

  • BlackRock Advisors held 138,294 shares of ChemoCentryx, Inc. worth $1.02M as of Q4 2016.
  • BlackRock Advisors sold 64,197 ChemoCentryx, Inc. shares in Q4 2016, an estimated $462K.
  • ChemoCentryx, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1848 holding.
  • BlackRock Advisors first reported a position in ChemoCentryx, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's ChemoCentryx, Inc. position peaked at $1.22M in Q3 2016.
  • 89 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.